Liposorber LA-15 System

Posted on Updated on

 Liposorber LA-15 System

The Liposorber LA-15 System is a blood processing system that is used outside the body. It includes disposable components and a control/monitor unit. The device works by removing certain lipoproteins from a patient’s blood. The Liposorber LA-15 System is used to treat pediatric patients with primary focal segmental glomerulosclerosis (FSGS) either before transplant, or after kidney (renal) transplantation in which there is recurrence of FSGS.

The Liposorber® LA-15 System is indicated for use in the treatment of pediatric patients with nephrotic syndrome associated with primary FSGS, when

  • Standard treatment options, including corticosteroid and/or calcineurin inhibitors treatments, are unsuccessful or not well tolerated and the patient has a GFR ≥ 60 ml/min/1.73m2 or
  • The patient is post renal transplantation










A patient’s blood is first passed through a plasma filter where the blood cells are separated from plasma (the liquid component of the blood). The plasma is then further passed through two adsorption columns, which are packed with a gel designed to capture the lipoproteins in the blood. The blood cells and the treated plasma are then returned to the patient via the blood return line.

Approval Date: October 10, 2013

Aurous HealthCare- CRO 5th Anniversary!

Posted on Updated on

5th_birthdayAurous HealthCare turned 5 this September and we couldn’t be more proud!!!

Apart from the celebrations at our Corporate Office, this year’s anniversary was marked with a significant event of Launching our Quarterly      Newsletter – AurouSpeak!AurouSpeak

AurouSpeak comes to you every quarter  with the latest information from the world of drug research and clinical trials in particular.

We would like to personally share a copy of the first edition of AurouSpeak with you..

(Click the link below to download. To subscribe, send a email to or

AurouSpeak-Sep13-Aurous HealthCare CRO Newsletter